Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Low Dose Acetylsalicylic Acid in Preventing Adverse Maternal and Perinatal Outcomes in SARS-CoV-2 Infected Pregnant Women

NCT05073718 is registered in ClinicalTrials.gov with Barcelona Institute for Global Health as lead sponsor.

NCT NCT05073718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05073718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Low Dose Acetylsalicylic Acid in Preventing Adverse Maternal and Perinatal Outcomes in SARS-CoV-2 Infected Pregnant Women
Lead sponsor
Barcelona Institute for Global Health
Phase
Phase 3
Overall status
Completed
Start date
September 14, 2022
Completion date
May 23, 2024
Enrollment
38 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-cov2 infection